Year: 2013
Type: article
Abstract: To improve and accelerate drug discovery, there is an urgent need for reliable and reproducible (animal and especially human) in vitro methods to test compounds for the treatment of liver diseases, such as viral hepatitis, NASH, fibrosis, and hepatocellular carcinoma. The in vitro models currently utilized in liver research cannot predict or mimic the complex cellular interactions that occur in vivo. Thus in isolated primary cells or cell lines, dedifferentiation rapidly occurs, partly due to the loss of the natural environment, including cues from the extracellular matrix and neighbouring or migratory cells.
Source: Journal of Hepatology
Authors: Peter Olinga, Detlef Schuppan
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $5,500
OpenAlex ID: W2102808931
